DYNEX CAPITAL INC (DX)

US26817Q8868 - REIT

11.595  +0.12 (+1%)

Fundamental Rating

2

Taking everything into account, DX scores 2 out of 10 in our fundamental rating. DX was compared to 64 industry peers in the Mortgage Real Estate Investment Trusts (REITs)" industry. DX has a bad profitability rating. Also its financial health evaluation is rather negative. DX is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

DX had negative earnings in the past year.
In the past year DX had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: DX reported negative net income in multiple years.
Each year in the past 5 years DX had a positive operating cash flow.

1.2 Ratios

The Return On Assets of DX (-0.79%) is worse than 76.56% of its industry peers.
DX's Return On Equity of -5.75% is on the low side compared to the rest of the industry. DX is outperformed by 82.81% of its industry peers.
Industry RankSector Rank
ROA -0.79%
ROE -5.75%
ROIC N/A
ROA(3y)2.01%
ROA(5y)1.63%
ROE(3y)8.41%
ROE(5y)4.42%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for DX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

DX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DX has been increased compared to 1 year ago.
Compared to 5 years ago, DX has more shares outstanding
The debt/assets ratio for DX is higher compared to a year ago.

2.2 Solvency

DX has an Altman-Z score of -1.11. This is a bad value and indicates that DX is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.11, DX is doing worse than 95.31% of the companies in the same industry.
The Debt to FCF ratio of DX is 87.25, which is on the high side as it means it would take DX, 87.25 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of DX (87.25) is comparable to the rest of the industry.
A Debt/Equity ratio of 6.23 is on the high side and indicates that DX has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 6.23, DX is doing worse than 82.81% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 6.23
Debt/FCF 87.25
Altman-Z -1.11
ROIC/WACCN/A
WACC5.31%

2.3 Liquidity

A Current Ratio of 0.03 indicates that DX may have some problems paying its short term obligations.
With a Current ratio value of 0.03, DX is not doing good in the industry: 85.94% of the companies in the same industry are doing better.
A Quick Ratio of 0.03 indicates that DX may have some problems paying its short term obligations.
DX has a Quick ratio of 0.03. This is amonst the worse of the industry: DX underperforms 85.94% of its industry peers.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03

6

3. Growth

3.1 Past

DX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -185.59%.
The Revenue has grown by 122.64% in the past year. This is a very strong growth!
DX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.79% yearly.
EPS 1Y (TTM)-185.59%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-900%
Revenue 1Y (TTM)122.64%
Revenue growth 3Y11.17%
Revenue growth 5Y3.79%
Revenue growth Q2Q328.05%

3.2 Future

The Earnings Per Share is expected to grow by 64.46% on average over the next years. This is a very strong growth
DX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 128.69% yearly.
EPS Next Y86.99%
EPS Next 2Y64.46%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year311.48%
Revenue Next 2Y128.69%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DX. In the last year negative earnings were reported.
Also next year DX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

DX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 10.91
EV/EBITDA N/A

4.3 Compensation for Growth

DX's earnings are expected to grow with 64.46% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y64.46%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 13.30%, DX is a good candidate for dividend investing.
DX's Dividend Yield is comparable with the industry average which is at 12.99.
DX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 13.3%

5.2 History

The dividend of DX decreases each year by -8.86%.
DX has been paying a dividend for at least 10 years, so it has a reliable track record.
DX has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-8.86%
Div Incr Years0
Div Non Decr Years2

5.3 Sustainability

DX has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-185.97%
EPS Next 2Y64.46%
EPS Next 3YN/A

DYNEX CAPITAL INC

NYSE:DX (4/19/2024, 9:19:56 AM)

11.595

+0.12 (+1%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryMortgage Real Estate Investment Trusts (REITs)"
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap678.77M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 13.3%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.79%
ROE -5.75%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 6.23
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-185.59%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y86.99%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)122.64%
Revenue growth 3Y11.17%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y